Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491836 |
US |
81 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 2 | 25492009 |
US |
76 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, TIRZEPATIDE, INSULIN GLARGINE, |
||||
| 3 | 25492017 |
US |
64 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, HUMAN INSULIN, |
||||
| 4 | 25492082 |
US |
18 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 5 | 25492131 |
US |
28 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 6 | 25492134 |
US |
77 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 7 | 25492287 |
US |
73 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 8 | 25492368 |
US |
78 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 9 | 25492510 |
US |
13 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 10 | 25492513 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 11 | 25492514 |
US |
11 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, |
||||
| 12 | 25492567 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 13 | 25492568 |
US |
66 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN ASPART, |
||||
| 14 | 25492627 |
SK |
2 | |
Retinal haemorrhage, Haemorrhage, Off label use, |
||||
BEVACIZUMAB, AFLIBERCEPT, |
||||
| 15 | 25492645 |
US |
19 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 16 | 25493011 |
US |
3 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 17 | 25493480 |
US |
39 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 18 | 25493535 |
US |
51 | 1 |
Haemorrhage, |
||||
| 19 | 25493726 |
US |
70 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 20 | 25494146 |
US |
||
Haemorrhage, Drug interaction, Haemoglobin decreased, Fatigue, |
||||
RELUGOLIX, RELUGOLIX, DIGOXIN, ENZALUTAMIDE, |
||||
| 21 | 25494375 |
US |
70 | 1 |
Haemorrhage, |
||||
TIRZEPATIDE, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 22 | 25494414 |
US |
1 | |
Haemorrhage, |
||||
| 23 | 25494506 |
DE |
3 | 2 |
Haemorrhage, Infection, |
||||
FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, ANTI-THYMOCYTE GLOBULIN (RABBIT), ANTI-THYMOCYTE GLOBULIN (RABBIT), BUSULFAN, BUSULFAN, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, THIOTEPA, THIOTEPA, RITUXIMAB, |
||||
| 24 | 25495135 |
US |
81 | 2 |
Hypertension, Haemorrhage, Abdominal discomfort, Malaise, |
||||
LENVATINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE BESYLATE, IRON, PEMBROLIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ONDANSETRON HYDROCHLORIDE, SIMVASTATIN, TRIAMTERENE CAPSULES, TRIAMTERENE, |
||||
| 25 | 25495288 |
US |
91 | 1 |
Haemorrhage, Anaemia, |
||||
APIXABAN, |
||||
| 26 | 25495329 |
US |
34 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 27 | 25495532 |
US |
59 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 28 | 25495939 |
US |
58 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 29 | 25495998 |
US |
82 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 30 | 25499341 |
72 | 2 | |
Atrial fibrillation, Device infusion issue, Haemorrhage, |
||||
| 31 | 25491200 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 32 | 25491269 |
US |
21 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 33 | 25491270 |
US |
62 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 34 | 25491295 |
US |
15 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 35 | 25491310 |
US |
64 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 36 | 25491374 |
US |
51 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 37 | 25491403 |
US |
63 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 38 | 25491640 |
US |
1 | |
Haemorrhage, |
||||
| 39 | 25500457 |
72 | 2 | |
Contusion, Haemorrhage, |
||||
DUPILUMAB, LEVOTHYROXINE, ROSUVASTATIN, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, ALPRAZOLAM, INSULIN GLARGINE, LISINOPRIL, EMPAGLIFLOZIN, |
||||
| 40 | 25490076 |
CA |
59 | 2 |
Cardiac failure congestive, Arthralgia, International normalised ratio increased, Stress, Upper gastrointestinal haemorrhage, Illness, Pain, Drug intolerance, Platelet count decreased, Haemorrhage, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, ETANERCEPT, |
||||
| 41 | 25490118 |
US |
58 | 1 |
Haemorrhage, |
||||
| 42 | 25490138 |
US |
23 | 1 |
Haemorrhage, |
||||
| 43 | 25490797 |
CA |
2 | |
Drug ineffective, Prescribed overdose, Rheumatoid factor positive, Hypertension, Off label use, Infusion related reaction, Abdominal discomfort, Therapeutic response decreased, Abdominal pain upper, Arthralgia, Condition aggravated, Therapeutic product effect decreased, Eye injury, Hepatic enzyme increased, Discomfort, Contraindicated product administered, Lower respiratory tract infection, Impaired healing, Musculoskeletal stiffness, Dizziness, Liver disorder, Abdominal pain, Pruritus, Ulcer, Injury, Confusional state, Oedema, Anti-cyclic citrullinated peptide antibody positive, Treatment failure, Systemic lupus erythematosus, Nausea, Fibromyalgia, Swelling, Maternal exposure during pregnancy, Intentional product use issue, Pericarditis, Hypersensitivity, Muscle injury, Folliculitis, Hand deformity, Pemphigus, Diarrhoea, Glossodynia, Type 2 diabetes mellitus, Duodenal ulcer, Liver injury, Gastrointestinal disorder, Pain, Alopecia, Lupus vulgaris, Rheumatoid arthritis, Nasopharyngitis, Synovitis, Joint swelling, Therapy non-responder, Perforation, Urticaria, Wheezing, General physical health deterioration, Swollen joint count increased, Fatigue, Infection, Product use issue, Drug intolerance, Irritable bowel syndrome, Chest pain, Blood cholesterol increased, Wound, Product use in unapproved indication, Ill-defined disorder, Rheumatic fever, Dyspnoea, Headache, Rash, Haemorrhage, Vomiting, Drug hypersensitivity, Psoriatic arthropathy, Helicobacter infection, |
||||
LEFLUNOMIDE, RITUXIMAB, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, SARILUMAB, LANSOPRAZOLE, ABATACEPT, CELECOXIB, CELECOXIB, GOLIMUMAB, HYDROCORTISONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, ASCORBIC ACID, TOCILIZUMAB, TOCILIZUMAB, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, INFLIXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, GOLIMUMAB, ADALIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, PREDNISONE, PREDNISONE, USTEKINUMAB, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, CERTOLIZUMAB PEGOL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, |
||||
| 44 | 25490880 |
US |
17 | 1 |
Haemorrhage, Wisdom teeth removal, |
||||
| 45 | 25490882 |
US |
56 | 1 |
Dermatitis atopic, Haemorrhage, Blister, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, METHYLPREDNISOLONE, PLECANATIDE, |
||||
| 46 | 25490913 |
US |
63 | 2 |
Rectal haemorrhage, Oral pain, Haemorrhage, Proctalgia, Gingival bleeding, |
||||
LAZERTINIB, FLUTICASONE PROPIONATE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ONDANSETRON HYDROCHLORIDE, |
||||
| 47 | 25484634 |
|||
Loss of consciousness, Intentional dose omission, Fall, Haemorrhage, |
||||
RIVAROXABAN, |
||||
| 48 | 25486366 |
US |
83 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 49 | 25486394 |
US |
2 | |
Headache, Visual impairment, Off label use, Feeling abnormal, Eye haemorrhage, Haemorrhage, |
||||
| 50 | 25486575 |
JP |
||
Haemorrhage, |
||||
| 51 | 25487073 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 52 | 25487201 |
US |
67 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 53 | 25487379 |
US |
83 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 54 | 25487410 |
US |
17 | 1 |
Haemorrhage, Joint injury, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 55 | 25487876 |
US |
1 | |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 56 | 25487948 |
US |
87 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 57 | 25488498 |
US |
66 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 58 | 25488501 |
US |
15 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 59 | 25488505 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 60 | 25488812 |
PH |
66 | 1 |
Haemorrhage, Haemoglobin decreased, |
||||
LORLATINIB, |
||||
| 61 | 25489111 |
US |
7 | 1 |
Haemorrhage, Head injury, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 62 | 25489113 |
US |
11 | 1 |
Haemorrhage, |
||||
| 63 | 25489660 |
US |
26 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 64 | 25489662 |
US |
73 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 65 | 25489664 |
US |
47 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 66 | 25489666 |
US |
72 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 67 | 25489855 |
TH |
81 | 1 |
Acute kidney injury, Urinary tract infection, Haemorrhage, Hypotension, Pallor, Lethargy, Fatigue, Off label use, |
||||
CETUXIMAB, |
||||
| 68 | 25489911 |
US |
84 | 1 |
Haemorrhage, |
||||
| 69 | 25489917 |
US |
1 | |
Peripheral swelling, Haemorrhage, Back pain, |
||||
EMICIZUMAB, |
||||
| 70 | 25490443 |
US |
5 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 71 | 25490522 |
US |
63 | 1 |
Haemorrhage, Haemorrhage, |
||||
| 72 | 25490860 |
CN |
62 | 1 |
Platelet count decreased, Fall, Headache, Haemorrhage, Coma, Traumatic haemorrhage, |
||||
CARBAMAZEPINE, CELECOXIB, |
||||
| 73 | 25494531 |
78 | 1 | |
Urinary retention, Haemorrhage, Thrombosis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 74 | 25481590 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 75 | 25481657 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 76 | 25481659 |
US |
19 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 77 | 25481782 |
US |
55 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, DULAGLUTIDE, INSULIN GLARGINE, |
||||
| 78 | 25481791 |
US |
48 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 79 | 25481799 |
US |
79 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 80 | 25481822 |
US |
54 | 2 |
Haemorrhage, |
||||
NICARDIPINE, |
||||
| 81 | 25482143 |
IE |
2 | |
Haemorrhage, |
||||
RISANKIZUMAB-RZAA, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 82 | 25482381 |
US |
78 | 1 |
Blood pressure abnormal, Haemorrhage, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FINASTERIDE, CALCIUM, |
||||
| 83 | 25482659 |
US |
68 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 84 | 25482755 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 85 | 25482975 |
US |
53 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 86 | 25483083 |
US |
11 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 87 | 25483089 |
US |
64 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 88 | 25483227 |
US |
67 | 1 |
Haemorrhage, |
||||
ETRASIMOD, |
||||
| 89 | 25483235 |
US |
1 | |
Haemorrhage, Peripheral swelling, Back pain, |
||||
EMICIZUMAB, |
||||
| 90 | 25483270 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 91 | 25483276 |
US |
45 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 92 | 25483277 |
US |
20 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 93 | 25483283 |
US |
12 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 94 | 25483373 |
US |
83 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 95 | 25483374 |
US |
66 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
| 96 | 25483377 |
US |
38 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 97 | 25483675 |
CA |
2 | |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Blood cholesterol increased, Chest pain, Condition aggravated, Confusional state, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Duodenal ulcer, Dyspnoea, Eye injury, Fatigue, Fibromyalgia, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Haemorrhage, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Liver disorder, Liver injury, Lower respiratory tract infection, Lupus vulgaris, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Off label use, Pain, Pemphigus, Perforation, Pericarditis, Prescribed overdose, Product use issue, Pruritus, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic response decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Ulcer, Urticaria, Vomiting, Wheezing, Wound, Adverse event, |
||||
ABATACEPT, RITUXIMAB, LANSOPRAZOLE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, GOLIMUMAB, SECUKINUMAB, SECUKINUMAB, USTEKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, CELECOXIB, CELECOXIB, TOCILIZUMAB, TOFACITINIB, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, INFLIXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, NAPROXEN, NAPROXEN SODIUM, LEFLUNOMIDE, SARILUMAB, ADALIMUMAB, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, CORTISONE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, |
||||
| 98 | 25483971 |
SK |
2 | |
Retinal haemorrhage, Haemorrhage, Off label use, |
||||
BEVACIZUMAB, AFLIBERCEPT, |
||||
| 99 | 25484439 |
US |
46 | 1 |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 100 | 25484825 |
US |
9 | 1 |
Coagulopathy, Haemorrhage, |
||||
BIVALIRUDIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29